Onesource Specialty Pharma Quarterly Results for Trading Insights

In Sept 2025, Onesource Specialty Pharma (ONESOURCE) reported revenue ₹379 Cr and net profit ₹11 Cr — revenue +12.1% YoY. For annual financials, live price and key ratios, visit Onesource Specialty Pharma stock price NSE .

Latest Quarter Net Profit
₹11 Cr
QSept 2025
Quarterly Results

ONESOURCE Quarterly Results — Revenue, Profit & EPS Highlights

Onesource Specialty Pharma latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Compare with ONESOURCE intrinsic value calculation to assess whether the stock is under or overvalued.

  • Revenue of ₹379 Cr in Sept 2025 (-11.7% vs Mar 2025, +12.1% vs Sept 2024)
  • Net Profit of ₹11 Cr in Sept 2025 (-88.9% vs Mar 2025, +126.2% vs Sept 2024)
  • EBITDA of ₹110 Cr in Sept 2025 (-40.5% vs Mar 2025)
  • Operating Margin of 28.0% in Sept 2025 (-15.0pp vs Mar 2025)
  • Earnings Per Share of ₹0.92 in Sept 2025 (-89.3% vs Mar 2025)

Onesource Specialty Pharma Quarterly Results — Revenue, EBITDA, Net Profit & EPS

ONESOURCE quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 QoQ YoY
Revenue (₹ Cr) 379 429 333 295 338 -11.7% 12.1%
Net Profit (₹ Cr) 11 99 0 -89 -42 - -
EBITDA (₹ Cr) 110 185 91 15 76 - -
EPS (₹) 0.92 8.61 -0.02 -7.74 -10.13 - -
Operating Margin (%) 28.0% 43.0% 26.0% 4.0% 21.0% - -

ONESOURCE Share Price Trend — 1-Year Movement Across Quarterly Results

Onesource Specialty Pharma 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Analyse ONESOURCE ownership pattern to track promoter, FII and institutional holdings.

Profitability Ratios

Profit Margin 2.9%
EBITDA Margin 29.0%
Operating Margin 28.0%
ROE (Annual) 0.7%

Balance Sheet Highlights

Total Assets ₹7,550 Cr
Total Equity ₹5,881 Cr
Current Assets ₹1,086 Cr
Current Liabilities ₹556 Cr

Cash Flow Analysis

Operating Cash Flow ₹-68 Cr
Investing Cash Flow ₹-201 Cr
Financing Cash Flow ₹412 Cr
Net Cash Flow ₹143 Cr

Current Market Data

Current Price ₹1545.10
Exchange NSE
Last Updated Apr 13, 2026

Revenue Trend (₹ Cr)

Dec 2025 295
Jun 2025 333
Mar 2025 429
Sept 2025 379

Net Profit Trend (₹ Cr)

Dec 2025 -89
Jun 2025 0
Mar 2025 99
Sept 2025 11

Operating Margin Trend (%)

Dec 2025 4.0%
Jun 2025 26.0%
Mar 2025 43.0%
Sept 2025 28.0%

ONESOURCE vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Onesource Specialty Pharma latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹396,418.12 Cr 1652.2 14,875 3,125 +10.8% - 21.0% 127.1
Divis Laboratories
Sept 2025 		₹162,373.86 Cr 6070.0 2,860 689 +7.1% - 24.1% 233.7
Torrent Pharmaceuti…
Sept 2025 		₹140,630.85 Cr 4181.0 3,219 591 +11.3% - 18.4% 238.4
Lupin
Sept 2025 		₹106,664.75 Cr 2315.1 6,921 1,485 +23.2% - 21.5% 71.5
Dr Reddys Laborator…
Sept 2025 		₹102,844.71 Cr 1235.9 9,135 1,337 +1.1% - 14.6% 76.4
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores